Yidong Wei | Immunology Cellular Interactions | Best Researcher Award

Posted on by sciencefather

Prof. Yidong Wei | Immunology Cellular Interactions | Best Researcher Award

Prof. Yidong Wei , Shanghai Tenth People’s Hospital, Tongji University , China

Dr. Yidong Wei, M.D., Ph.D., FACC, is a distinguished professor and the Chief of Cardiology at Shanghai Tenth People’s Hospital, Tongji University. He also holds a clinician management role at the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford. With a strong foundation in both clinical and translational research, Dr. Wei has built an internationally recognized career focused on interventional cardiology, cardiac electrophysiology, and cardiovascular epidemiology. He is a Fellow of the American College of Cardiology, reflecting his global academic influence. Known for bridging clinical care with bench-side discovery, his work has advanced understanding in myocardial infarction, heart failure, and calcium signaling in cardiomyocytes. With numerous high-impact publications and leadership in multicenter registries like NOAFCAMI-SH, Dr. Wei’s contributions are widely cited and clinically relevant. His dual academic and clinical roles across China and the UK highlight his dedication to innovation, international collaboration, and excellence in cardiovascular medicine.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. High-Impact Research Output:
    Dr. Wei has authored or co-authored more than 18 recent peer-reviewed publications in prestigious journals such as Diabetes Metabolism Research and Reviews, Redox Biology, Cardiovascular Diabetology, and ESC Heart Failure. Many of these works are already cited, indicating early academic impact and relevance.

  2. Dual Focus – Basic and Clinical Science:
    His research bridges the gap between molecular mechanisms (e.g., calcium signaling, TRIM21, PTEN) and clinical cardiology (e.g., atrial fibrillation, myocardial infarction, cardiac remodeling), highlighting a robust translational focus.

  3. Leadership and Collaboration:
    He serves as Chief of Cardiology at Shanghai Tenth People’s Hospital and a Clinician Manager at the University of Oxford, demonstrating international leadership and cross-border collaboration.

  4. Registry Leadership (NOAFCAMI-SH):
    His work through the NOAFCAMI-SH registry provides real-world evidence on cardiovascular disease progression, risk prediction, and treatment response—critical for patient-centered care.

  5. Prestigious Recognition:
    Dr. Wei is a Fellow of the American College of Cardiology (FACC), a title reserved for top-tier cardiovascular professionals with sustained excellence.

⚠️ Areas for Improvement:

  1. Broader International Research Leadership:
    While Dr. Wei has strong China–UK collaborations, leading global multicenter clinical trials or international consortia would further solidify his standing.

  2. Public Engagement and Knowledge Translation:
    Though academically prolific, increased involvement in public health education or policy advocacy could amplify the real-world impact of his research.

  3. Mentorship Track Record Visibility:
    Highlighting mentorship of junior researchers and postdocs more explicitly in profiles and bios would enhance his case for a holistic academic leadership award.

🎓 Education:

Dr. Wei began his medical education at Henan Medical University, where he completed clinical training with a focus on cardiovascular medicine. Driven by a passion for research, he pursued and completed his Ph.D. in 2004, with a specialization in cardiac electrophysiology and calcium signaling pathways. His graduate studies were complemented by advanced basic science training at the University of Kentucky, USA, a leading institution in biomedical research. Between 2004 and 2006, Dr. Wei completed postdoctoral research, focusing on the molecular mechanisms of cardiac dysfunction and electrophysiology. His educational background reflects a balanced integration of rigorous clinical education and innovative research development, equipping him with the tools necessary to bridge bedside care with laboratory insights. This foundation has allowed Dr. Wei to contribute to both academic medicine and cutting-edge cardiovascular research, distinguishing him as a leader with comprehensive and global training in the field.

🏥 Experience:

With over two decades of experience, Dr. Yidong Wei serves as Professor and Chief of the Department of Cardiology at Shanghai Tenth People’s Hospital, Tongji University. His role extends internationally, acting as Clinician Manager at the University of Oxford’s Centre for Diabetes, Endocrinology and Metabolism. His clinical expertise spans interventional cardiology, acute coronary syndromes, and electrophysiological interventions, while his research roles emphasize trial design, biomarker discovery, and cellular cardiology. He has led and contributed to large-scale registries like NOAFCAMI-SH, generating evidence that informs guidelines for myocardial infarction and atrial fibrillation. His professional experience combines healthcare leadership, cross-border academic collaboration, and impactful research. As a Fellow of the American College of Cardiology, he is actively engaged in academic societies and peer-reviewed journals. Dr. Wei’s experience reflects an enduring commitment to patient care, innovation in research, and mentorship of future cardiology leaders, marking him as a high-impact contributor in his field.

🔬 Research Focus:

Dr. Yidong Wei’s research lies at the intersection of clinical cardiology and molecular medicine. He focuses on interventional cardiology, atrial fibrillation, myocardial infarction, and calcium signaling pathways in cardiac myocytes. A major theme in his work is the electrophysiological basis of heart failure and age-related changes in ventricular function. Using techniques like patch clamping, calcium imaging, laser confocal microscopy, and molecular biology, he investigates calcium channel regulation and excitation-contraction coupling in cardiac cells. Clinically, he leads research through the NOAFCAMI-SH registry, analyzing systemic inflammation, hyperglycemia, atrial fibrillation, and long-term cardiac outcomes. His work advances the understanding of post-infarction remodeling and atrial pathology. Combining basic science with real-world data, Dr. Wei’s research bridges gaps in translational cardiology and offers therapeutic targets for chronic cardiac conditions. His integrative approach makes him a pioneer in translating bench findings into bedside impact, with potential to redefine cardiac care strategies globally.

📚 Publications Top Notes:

  1. 📈 Association of stress hyperglycemia ratio with atrial fibrillation and outcomes in myocardial infarction

  2. 🧪 Prognostic implications of systemic immune-inflammation index in MI patients with and without diabetes

  3. 🧬 TRIM21 deficiency protects heart post-MI by reducing oxidative stress

  4. 🫀 4S-AF scheme for characterizing atrial fibrillation after myocardial infarction

  5. 🔬 TRIM21 worsens cardiac injury via M1 macrophage polarization post-MI

  6. 🧮 Stress hyperglycemia and outcomes in MI with and without diabetes mellitus

  7. 💉 ZPI protects endothelium via PI3K/Akt pathway activation against ox-LDL

  8. 📊 Atrial fibrillation’s prognosis across heart failure subtypes post-MI

  9. 🕒 Five-year outcomes post left atrial appendage occlusion

  10. 🧫 PTEN and serum deprivation-induced cytotoxicity via PI3K/AKT pathway

🧾 Conclusion:

Dr. Yidong Wei stands out as a highly suitable candidate for the Best Researcher Award. His contributions to cardiovascular research—spanning cutting-edge basic science to influential clinical trials—are both innovative and impactful. His leadership roles, international presence, and translational focus align perfectly with the goals of this prestigious recognition. Given his trajectory, Dr. Wei is not only a leader in current cardiovascular research but also a driver of future scientific breakthroughs.

WEI HUANG | Mitochondrial Function Dynamics | Best Researcher Award

Posted on by sciencefather

Dr. WEI HUANG | Mitochondrial Function Dynamics | Best Researcher Award

Dr. WEI HUANG , Aier Glaucoma Institute, Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials, Changsha Aier Eye Hospital , China

Dr. Wei Huang is a highly skilled ophthalmologist with a robust background in clinical and experimental ophthalmology. She earned her Bachelor’s in Clinical Medicine from Shanxi Medical University (2010-2013), followed by a Master’s and Ph.D. in Ophthalmology from Xiangya Medical School, Central South University (2013-2021). Dr. Huang has made significant contributions to dry eye disease, stem cell therapy, and ocular pharmacology. She currently works as an ophthalmologist at Changsha Aier Eye Hospital, continuing her research on dry eye inflammation and novel therapeutic agents. With extensive experience in clinical trials, pre-clinical drug development, and molecular biology, she has been a key researcher in various cutting-edge studies. Her dedication to advancing ophthalmic treatments is evident in her numerous publications, many of which focus on innovative drug delivery systems and stem cell applications in eye diseases. Dr. Huang’s expertise has earned her recognition in both China and the U.S. for her scientific contributions.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Academic Background:

    • Huang Wei has an impressive academic background in Clinical Medicine and Ophthalmology, holding a Ph.D. from Central South University, as well as significant post-graduate experience in clinical settings. She has gained comprehensive expertise through various prestigious institutions, including work as a Senior Research Support Specialist at the State University of New York and as an ophthalmologist at Sun Yat-sen Memorial Hospital and Changsha Aier Eye Hospital.

  2. Exceptional Research Experience:

    • Huang’s research contributions, particularly in ophthalmology, dry eye disease, stem cells, and drug development, have led to numerous publications in high-impact journals like the Journal of Ocular Pharmacology and Therapeutics and Experimental Eye Research. She has been the lead researcher and coordinator on multiple successful projects and clinical trials, particularly focused on innovative drug therapies and experimental models.

  3. Pioneering Drug Development and Stem Cell Research:

    • Her research involving human umbilical cord blood-derived mesenchymal stem cells for regenerative medicine and her clinical trial work with novel NSAID formulations for dry eye disease showcases her pioneering role in advancing both pre-clinical and clinical drug development.

  4. Expert in Ophthalmological Techniques:

    • Huang demonstrates proficiency in a wide range of advanced experimental and clinical techniques, including ocular microsurgery, advanced imaging, animal modeling, and molecular biology. Her expertise in both basic science and clinical research equips her to bridge the gap between laboratory findings and clinical applications, which is an essential aspect of impactful medical research.

  5. Leadership and Recognition:

    • She has earned full scholarships for both her M.S. and Ph.D., demonstrating strong academic excellence. Additionally, her publication record is robust, with over 16 peer-reviewed journal articles and several key contributions to research projects focused on eye disease mechanisms and therapies.

  6. Global Recognition:

    • Her collaborative work across international institutions, coupled with her ability to bring together multiple research teams and fields, places her at the forefront of ophthalmic and medical research. Her work is highly regarded, and she holds substantial influence in the field of dry eye disease research.

Areas for Improvement:

  1. Broader Public Engagement and Outreach:

    • While Huang’s contributions to peer-reviewed journals and clinical settings are undeniable, expanding her involvement in public outreach, particularly to raise awareness about new treatments in ophthalmology or stem cell research, could increase her visibility and engagement within the broader medical and patient communities.

  2. Diverse Collaborative Networks:

    • Huang has primarily worked within the realm of ophthalmology and stem cell research. Exploring cross-disciplinary collaborations outside of ophthalmology, such as in molecular genetics, biomedical engineering, or artificial intelligence for drug development, could further diversify her research impact and innovation.

  3. Leadership in Research Strategy and Funding:

    • Although she has demonstrated strong leadership in individual research projects, Huang could work toward taking on more leadership roles in strategic planning, grant applications, and the overall direction of large-scale research initiatives. This would solidify her role not only as a researcher but as a leader in the field of medical research.

Education:

Dr. Wei Huang began her academic journey at Shanxi Medical University, where she completed her Bachelor of Science in Clinical Medicine between 2010 and 2013. She then pursued her M.S. and Ph.D. in Ophthalmology at Xiangya Medical School, Central South University, one of the top medical institutions in China. During her Ph.D. studies (2013-2021), Dr. Huang focused on ocular pharmacology and stem cell therapies, particularly in the context of retinal diseases and dry eye syndrome. Her research has been supported by various prestigious grants, including the National Natural Science Foundation of China, underscoring her academic excellence. Throughout her education, she received full scholarships for her Master’s and Ph.D. programs. Her educational journey reflects a strong commitment to ophthalmology, evidenced by her continuous pursuit of both theoretical knowledge and practical experience in the field of eye care and treatment development.

Experience:

Dr. Wei Huang has gained extensive experience in both research and clinical ophthalmology. She worked as a Senior Research Support Specialist at the Medicine Department of the State University of New York from 2017 to 2020, focusing on ocular disease models and pre-clinical drug development. In 2021, she transitioned to clinical practice as an Ophthalmologist and Post-Ph.D. researcher at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, where she led studies on ocular inflammation and dry eye disease. In 2023, she joined Changsha Aier Eye Hospital, continuing her clinical practice while conducting cutting-edge research on ocular inflammation and therapeutic interventions. Dr. Huang’s research skills span ocular microsurgery, clinical trials, and molecular biology, making her a leader in ophthalmological innovations. Throughout her career, she has made significant contributions to the treatment of dry eye disease, retinal degeneration, and optic neuropathy, with a focus on drug development and stem cell therapies.

Awards and Honors:

Dr. Wei Huang has received numerous prestigious awards for her academic and professional achievements. She was honored with a Ph.D. Full Scholarship from Central South University (2016-2019) and an M.S. Full Scholarship (2013-2016), recognizing her exceptional academic potential and research contributions. Additionally, she received the B-level Scholarship from Shanxi Medical University (2008-2013) during her undergraduate studies. Her academic excellence has led to her selection for various research projects funded by the National Natural Science Foundation of China. She has also earned a Professional Medical License, validating her clinical expertise. Dr. Huang’s dedication to research has been recognized internationally, with multiple publications in high-impact journals, further solidifying her reputation in the ophthalmology community. As a certified Good Clinical Practice (GCP) professional in both China and the U.S., she continues to contribute to advancing ophthalmic therapies through rigorous clinical trials and innovative treatments.

Research Focus:

Dr. Wei Huang’s research primarily focuses on ophthalmology, with a particular emphasis on dry eye disease, stem cell therapy, and the development of novel pharmacological treatments for ocular conditions. Her work includes exploring the use of mesenchymal stem cells from human umbilical cord blood in treating retinal ganglion cells and optic nerve regeneration, a project funded by the National Natural Science Foundation of China. She also leads research in pre-clinical drug development for dry eye syndrome, investigating the effectiveness of phospho-modified NSAIDs in treating ocular inflammation. Dr. Huang is deeply involved in clinical trials, including those exploring the safety and efficacy of novel treatments for primary open-angle glaucoma and traumatic optic neuropathy. She is currently investigating the mechanisms behind Sjögren’s syndrome-associated dry eye inflammation and the potential for mitochondrial fatty acid oxidation to inhibit this inflammation. Dr. Huang’s research aims to transform the therapeutic landscape of various ocular diseases, improving patient outcomes.

Publications Top Notes:

  1. Hydrogel formulation of phosphosulindac allows once-a-day ocular dosing and limits its biodistribution to the anterior chamber: Application to dry eye disease treatment 🧴👁️

  2. Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration 🧬👀

  3. Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models 🐇💧

  4. Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect 🧪🧴

  5. Animal models of dry eye disease: Useful, varied and evolving (Review) 📚🔬

  6. Simplified ex-vivo drug evaluation in ocular surface cells: Culture on cellulose filters of cells obtained by impression cytology 🔬🧫

  7. The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye 🧬👁️

  8. Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits 🐰🔬

  9. NSAID-induced corneal melt: Clinical importance, pathogenesis, and risk mitigation 💉🧑‍⚕️

Conclusion:

Dr. Huang Wei is a highly qualified and accomplished researcher with outstanding contributions to the field of ophthalmology, particularly in the development of new treatments for dry eye disease and regenerative medicine. Her extensive research experience, coupled with her leadership roles in clinical trials and drug development, makes her an ideal candidate for the Best Researcher Award.

Weifen Zhang | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Weifen Zhang | Cancer Cell Biology | Best Researcher Award

Prof. Weifen Zhang , Shandong Second Medical University , China

Professor Weifen Zhang is a renowned scientist in pharmaceutical sciences, serving as a Professor at the School of Pharmacy, Shandong Second Medical University. She also directs the Shandong Engineering Research Center for Intelligent Materials and Regenerative Medicine and the Pharmaceutical Experimental Teaching Center. With over 50 SCI-indexed publications and 27 national and international patents, her contributions have significantly influenced the development of targeted drug delivery systems and smart biomaterials. A recipient of the State Council Special Allowance and recognized as a Shandong Provincial Outstanding Expert, Professor Zhang combines academic excellence with practical innovation. She has led and collaborated on numerous national-level research projects, focusing on novel therapeutic strategies for cancer, regenerative medicine, and nano-drug technologies. Additionally, she plays a prominent role in scientific publishing as a guest editor and reviewer for leading journals. Her dedication to interdisciplinary research continues to shape the future of pharmaceutical technology.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. 📚 High Research Productivity: Over 50 SCI-indexed publications in high-impact journals such as ACS Applied Materials & Interfaces, Journal of Biomedical Nanotechnology, and Science China Materials.

  2. 💡 Innovation & Intellectual Property: Holds 27 national and international patents, showing a strong translation of academic work into real-world applications.

  3. 🔬 Research Focus & Impact: Cutting-edge work in targeted drug delivery systems, intelligent biomaterials, and regenerative medicine, especially impactful in oncology.

  4. 🎯 Project Leadership: Principal Investigator for multiple nationally funded projects, managing significant funding amounts and driving original discoveries.

  5. 🌐 Academic Influence: Serves as a guest editor and reviewer for leading scientific journals, contributing to quality control and peer knowledge advancement.

  6. 📖 Educational Impact: Contributions to national-level textbooks like Pharmaceutics and Pharmaceutical English highlight her role in shaping future pharmaceutical education.

  7. 🤝 Industry Collaboration: Active collaborations with companies like NOIMAIER (Shandong) Medical Technology Co., Ltd, demonstrating practical application and outreach.

⚠️ Areas for Improvement:

  1. 🌍 Global Outreach: While her influence is strong nationally, increased participation in international conferences, collaborations, and global visibility would further elevate her stature.

  2. 🎙️ Public Engagement: Enhanced involvement in science communication, including talks, public articles, or media, could broaden her societal impact.

  3. 🌐 Online Presence: A more visible online research profile (e.g., Google Scholar, ResearchGate, LinkedIn) could help in networking and research dissemination globally.

🎓 Education:

Professor Weifen Zhang received comprehensive training in pharmaceutical sciences, culminating in a doctorate in pharmacy or a related biomedical field (specific degree and institution not provided in the current profile). Her academic journey has been deeply rooted in advancing applied pharmaceutical research, especially in the field of drug delivery and intelligent materials. Her educational background laid the foundation for her specialization in nanoformulations, regenerative medicine, and drug resistance reversal. Professor Zhang has supplemented her academic credentials with continued professional development through her work with major national science foundations and governmental innovation programs. Her commitment to combining traditional pharmaceutical training with cutting-edge material science has enabled her to become a leader in translational research. Although the detailed degrees and institutions are not specified, her track record in high-impact research, publications, and academic leadership reflects a strong and diverse educational background.

🧪 Experience:

Professor Zhang brings over two decades of experience in pharmaceutical sciences, nanomedicine, and biomaterial engineering. She has served in multiple leadership roles, including Director of both the Shandong Engineering Research Center for Intelligent Materials and Regenerative Medicine and the Pharmaceutical Experimental Teaching Center at Shandong Second Medical University. As Principal Investigator on numerous high-profile projects funded by the National Natural Science Foundation of China and regional innovation programs, she has demonstrated excellence in both basic and translational research. Her industrial collaborations and consultancy projects, such as those with NOIMAIER Medical Technology, reflect her ability to translate scientific innovation into practical solutions. Her experience is also reflected in her active editorial and peer review contributions to top-tier journals, as well as her involvement in educational contributions through national textbook projects. Her academic, industrial, and clinical translational experiences make her a uniquely qualified and impactful researcher.

🔬 Research Focus:

Professor Weifen Zhang’s research is at the forefront of targeted drug delivery, intelligent biomaterials, and regenerative medicine. Her primary scientific focus involves developing novel nanoparticle-based platforms to improve therapeutic outcomes in diseases such as non-small cell lung cancer. She has led pioneering studies in dual-drug synergistic delivery, utilizing agents like quercetin and paclitaxel, aimed at overcoming drug resistance. Her lab also explores smart, biodegradable materials, such as Bletilla striata polysaccharide microneedles, for innovative therapeutic applications including hair regrowth and skin regeneration. In regenerative medicine, she is advancing bionic materials, such as mineralized collagen scaffolds, for orthopedic and dental use. Additionally, she works on plant-derived compounds, contributing to both pharmaceutical and agricultural solutions. Through interdisciplinary approaches, including nanotechnology, immunology, and pharmacokinetics, Professor Zhang’s work is positioned to influence both academic research and clinical practice. Her vision continues to shape the field of personalized and precision medicine.

📚 Publications Top Notes:

  1. 📌 Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth

  2. 🧱 Composite scaffolds based on egg membrane and eggshell-derived inorganic particles promote soft and hard tissue repair

  3. 💉 Efficient chemo-immunotherapy leveraging minimalist electrostatic complex nanoparticle as “in situ” vaccine integrated tumor ICD and immunoagonist

  4. 🌿 A Chinese drug-compatibility-based approach to purslane hydrogels for acute eczema therapy

  5. 🔬 Dynamic Covalent Bond-Based Nanoassembly of Curcumin to Enhance the Selective Photothermal Therapy for Tumor Treatment

  6. 🧵 Multifunctional Nanofiber Membranes Constructed by Microfluidic Blow-Spinning to Inhibit Scar Formation at Early Intervention Stage

  7. 📄 Corrigendum to “Synergistically enhanced cancer immunotherapy by combining protamine-based nanovaccine with PD-L1 gene silence nanoparticle”

  8. 💉 Minimalist “in situ” tumor vaccine leveraging versatile dendrimer nanoplatform coordinated ICD and immunoagonist for boosted chemoimmunotherapy

  9. 🧬 A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy

  10. ⚗️ Biodegradable Manganese-Containing Mesoporous Silica Nanoparticles for Precisely Controlled Quercetin Delivery

 

📌 Conclusion:

Professor Weifen Zhang demonstrates exceptional qualifications for the Best Researcher Award. Her deep scientific contributions, robust patent portfolio, influential publications, and national leadership in pharmaceutical innovation mark her as a leader in biomedical research. With a few enhancements in global visibility and science communication, her already impressive profile could reach even greater heights.

Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Posted on by sciencefather

Dr. Salam Bani Hani | Cell Structure Analysis | Best Researcher Award

Dr. Salam Bani Hani , Irbid National University , Jordan

Dr. Salam Bani Hani is an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She holds a PhD in Nursing Philosophy from the University of Jordan, where she earned a perfect GPA of 4/4. She also holds an MSc in Nursing Service Administration from Jordan University of Science and Technology and a BSN from Al-Al Bayt University. Dr. Bani Hani has a strong academic background, and her research primarily focuses on nursing documentation, healthcare data, and predictive models in healthcare. In addition to her academic role, she has extensive clinical experience, having worked as a patient and family educator in Qatar and a clinical instructor at Al-Al Bayt University. She has made significant contributions to nursing education and research, publishing numerous studies in international journals and presenting at conferences globally. Her expertise bridges clinical practice and academic advancement.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Salam Bani Hani demonstrates remarkable expertise in nursing research, with a clear focus on the integration of technology and data analytics in healthcare. Her work on using large-scale data to predict ischemic heart disease and her contributions to nursing documentation through comparative studies of paper-based and electronic health records reflect her ability to tackle relevant, contemporary issues in healthcare. Her research has been widely published in respected journals, with numerous articles on topics such as digital health literacy, the use of artificial intelligence in healthcare, and predicting mortality in heart disease patients. Her academic excellence, reflected in her perfect PhD GPA, coupled with her extensive teaching experience, makes her an exemplary candidate for this award.

Areas for Improvement:

While Dr. Bani Hani’s academic and clinical achievements are impressive, further engagement in collaborative, interdisciplinary research could enhance the impact of her work. Additionally, expanding her outreach through international conferences and workshops could elevate her profile even further.

Education:

Dr. Salam Bani Hani holds a PhD in Nursing Philosophy from the University of Jordan (2019–2022), graduating with an exceptional GPA of 4/4. Her dissertation focused on predicting ischemic heart disease in the Jordanian population using large-scale data. She also holds a Master of Science in Nursing (MSc) in Nursing Service Administration from Jordan University of Science and Technology, where she received a GPA of 94.1. Her thesis explored the quality of nursing documentation, comparing paper-based and electronic health records. She completed her Bachelor of Science in Nursing (BSN) at Al-Al Bayt University in 2011 with an excellent GPA of 88.7. Dr. Bani Hani’s academic achievements are complemented by various specialized training courses, including life support, pain management, and simulation education, all of which contribute to her comprehensive expertise in nursing and healthcare.

Experience:

Dr. Salam Bani Hani currently serves as an Assistant Professor and Head of the Nursing Department at Irbid National University, Jordan. She has been in this role since November 2023. Previously, she was a Clinical Instructor at Al-Al Bayt University, teaching across various nursing fields such as medical-surgical, emergency, and critical care. She has also served as a Patient and Family Educator at Hamad Medical City, Qatar, from 2018 to 2019. Dr. Bani Hani started her clinical career as a Staff Nurse in the emergency ward at Jordan University Hospital, one of the leading hospitals in the Middle East. She has extensive experience in both clinical practice and teaching, specializing in nursing education, patient care, and healthcare management. Additionally, she actively participates in various professional development programs and workshops, contributing significantly to both academia and practice in the nursing field.

Awards and Honors:

Dr. Salam Bani Hani has received numerous accolades in recognition of her academic and professional achievements. She earned the highest honors in her PhD studies, graduating with a perfect GPA of 4/4 from the University of Jordan. Throughout her career, she has contributed to advancing nursing education and practice, and her work has been published in several prestigious journals. Additionally, she has been involved in organizing and attending key nursing conferences, including the 2nd International Nursing Conference in 2023. Dr. Bani Hani’s work in the realm of healthcare data analysis, digital health, and nursing documentation has earned her recognition in both academic and clinical settings. Her dedication to improving healthcare delivery through research and education has been recognized by peers and institutions, positioning her as a leader in the nursing profession. She has also contributed significantly to nursing education through various workshops and specialized training programs.

Research Focus:

Dr. Salam Bani Hani’s research focuses on the intersection of nursing education, digital health, and predictive healthcare models. Her PhD dissertation explored the use of large-scale data to predict ischemic heart disease among the Jordanian population, which aligns with her research interest in healthcare data analytics. She has extensively researched nursing documentation, comparing paper-based versus electronic health records, and has contributed to advancing the field of digital health literacy. Dr. Bani Hani is particularly interested in the application of artificial intelligence (AI) and machine learning in healthcare, with research that investigates how AI can be used to improve patient care and support healthcare decision-making. Her work also delves into the competencies required for oncology nurses and the role of technology in improving clinical practices. Additionally, she has explored the impact of COVID-19 on nursing practices and is actively involved in enhancing nursing education through blended learning and interactive training.

Publications Top Notes:

  • Quality of nursing documentation: Paper‐based health records versus electronic‐based health records 📚
  • Machine-learning algorithms for ischemic heart disease prediction: a systematic review 💻
  • Attitudes of Jordanian Oncology Nurses Toward Computerization 📊
  • Electronic health literacy and its association with lifestyle behavior among undergraduate students 💡
  • Assessment of genetic variation among Jordanian barley landraces (Hordeum vulgare L.) 🌾
  • Large-scale data in health care: a concept analysis 🏥
  • Transforming cancer clinical trials: The integral role of artificial intelligence in electronic health records 🤖
  • Effective prediction of mortality by heart disease among women in Jordan using the chi-squared automatic interaction detection model 🩺
  • Effectiveness of blended learning basic life support module on knowledge and skills: A systematic review of randomized controlled trials 💡
  • Assessing digital health literacy level among nurses in Jordanian hospitals 🏥

Conclusion:

Dr. Salam Bani Hani is highly deserving of the Research for Best Researcher Award. Her consistent contributions to advancing nursing practice, her innovative use of technology in healthcare, and her rigorous academic achievements reflect her commitment to improving patient care and nursing education. With her comprehensive skill set and dedication, she continues to make significant strides in both clinical and academic research, positioning her as a leader in her field.

 

 

 

Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr. Priyanshu Mathur , SMS Medical College, Jaipur , India

Dr. Priyanshu Mathur is an esteemed expert in Pediatric Medicine and Genetics, serving as an Associate Professor at SMS Medical College, Jaipur, India. He is renowned for his pioneering work in rare diseases, neurometabolism, and newborn screening. With a robust academic background, Dr. Mathur holds an MD in Pediatrics, a PhD in Genetics (Honorary), and specialized training in clinical biochemical genetics and neurometabolism. He is actively involved in clinical research and education, focusing on inborn errors of metabolism and rare genetic disorders. Dr. Mathur’s leadership extends to founding India’s first Rare Diseases Registry and establishing a newborn screening lab. He has significantly impacted both clinical practice and academic spheres in India and abroad. He is an active member of various international networks and has contributed extensively to medical research and education, solidifying his position as a thought leader in pediatric genetics and rare diseases.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Priyanshu Mathur exhibits a profound commitment to advancing pediatric medicine, particularly in the fields of genetics, neurometabolism, and rare diseases. His extensive academic and clinical contributions make him an exceptional candidate for the Best Researcher Award. Below are the key strengths that highlight his qualifications:

  1. Educational Excellence:
    • Dr. Mathur’s advanced qualifications, including a Masters in Neurometabolism & Cell Biology from the University of Barcelona and a Fellowship in Clinical Biochemical Genetics & Newborn Screening in the USA, underscore his expertise in rare metabolic disorders and genetic diseases.
    • His honorary PhD in Genetics further exemplifies his contributions to genetic research and medicine.
  2. Research and Clinical Leadership:
    • He has been instrumental in establishing the first Indian Rare Diseases Registry, which has provided valuable insights into rare disease prevalence in India (www.rarediseasesregistryindia.com).
    • His work in newborn screening and biochemical genetics, including his leadership in starting the NBS lab at J K Lone hospital, Jaipur, demonstrates a significant impact on early detection and management of genetic disorders.
    • His role as a Principal Investigator (PI) in DBT and ICMR-approved research projects highlights his ability to lead national-level research initiatives.
  3. Publication Record and Recognition:
    • Dr. Mathur has contributed extensively to the scientific literature, with numerous original articles and case reports, often focusing on rare diseases, pediatric genetics, and metabolic disorders.
    • His published works, along with his contributions to textbooks such as Rare Diseases in Pediatrics, exemplify his thought leadership.
    • He is also actively involved in peer review, further demonstrating his academic credibility.
  4. Clinical and Teaching Experience:
    • With years of experience as an Associate Professor at SMS Medical College and as a consultant at J K Lone Hospital, Dr. Mathur has shown excellence in clinical practice and teaching.
    • He is deeply involved in mentoring postgraduate students, guiding them in the fields of genetics and pediatrics, and helping shape the next generation of medical professionals.
  5. National and International Impact:
    • Dr. Mathur’s expertise is internationally recognized, with participation as a speaker and panelist at various international summits, including NBS Virtual Summit and Emory University sessions.
    • His role as a national faculty member for IAP programs and his advisory positions with organizations such as the Rare Disease India Foundation further underscore his leadership.

Areas for Improvement:

  1. Expansion of Research Focus:
    • Although Dr. Mathur has made immense contributions in metabolic genetics and rare diseases, there is potential for further exploration into emerging areas such as gene therapy, CRISPR-based technologies, and personalized medicine.
    • Collaborating with multidisciplinary teams to explore integrative approaches to pediatric genetic disorders could enrich his research portfolio.
  2. Further International Collaboration:
    • Increasing international collaborations, particularly in the context of clinical trials and large-scale multicenter studies, could significantly enhance the global impact of his work. This could provide broader insights and validation of his findings across diverse populations.
  3. Public Outreach and Advocacy:
    • While his contributions to academia are remarkable, further emphasis on public outreach programs to raise awareness about rare diseases and genetic conditions could increase their visibility in India and beyond.
    • Engaging with patient advocacy groups could help bridge the gap between research and patient care.

Education:

Dr. Priyanshu Mathur’s educational journey showcases a deep commitment to advancing knowledge in pediatric medicine and genetics. He earned his MBBS in 2005 from Vijayanagar Institute of Medical Sciences, Bellary, Karnataka, India, where he secured the first rank. He completed his MD in Pediatrics in 2010 from Dr. S. N. Medical College, Jodhpur, Rajasthan, India. His academic pursuits include a Masters in Neurometabolism & Cell Biology for Clinicians from the University of Barcelona, Spain (2022-2024). Dr. Mathur also underwent a Fellowship in Metabolic Genetics and Newborn Screening in Atlanta, USA (2018-2019), strengthening his expertise in the diagnosis and management of genetic disorders. His honorary PhD in Genetics from IIU in 2021 further bolstered his academic stature. His education equips him with an exceptional foundation in clinical genetics, pediatrics, and research, allowing him to contribute meaningfully to the field of medical science.

Experience:

Dr. Priyanshu Mathur’s professional experience spans over a decade, making him a leader in pediatric medicine and genetics. He is currently an Associate Professor at SMS Medical College, Jaipur, where he teaches and mentors future medical professionals. Dr. Mathur’s clinical expertise is evident in his role at J K Lone Hospital, Jaipur, where he oversees the Rare Diseases Clinic and newborn screening services. His experience extends internationally, having worked as a visiting assistant professor in clinical biochemical genetics and newborn screening in Atlanta, USA. He is deeply involved in clinical research, particularly in the field of genetic disorders and rare diseases, and has contributed to several national and international research projects. Dr. Mathur’s teaching roles include guiding postgraduate students and being a faculty member for various national courses and workshops. His work in establishing the first Indian Rare Diseases Registry and newborn screening lab has had a transformative impact on Indian healthcare.

Awards and Honors:

Dr. Priyanshu Mathur has earned multiple prestigious awards throughout his career, recognizing his dedication to research, teaching, and clinical excellence. In 2021, he received an Honorary Doctorate (PhD) in Genetics from IIU for his outstanding contributions to genetics and pediatric medicine. He was awarded a Fellowship in Clinical Biochemical Genetics & Newborn Screening in 2019, marking his specialization in metabolic genetics. In the same year, he received the Outstanding Faculty Award from the Principal of SMS Medical College, Jaipur, for his exceptional contributions to education. Dr. Mathur was also honored with the “Dakshata Praman Patra” at SMS Medical College, Jaipur, in 2016. Earlier in his career, he won the Silver Medal for paper presentation at a State Pediatric Conference in 2009 and was recognized as the Best Outgoing Student at VIMS, Bellary, in 2005. His awards reflect his commitment to advancing medical science and improving healthcare delivery.

Research Focus:

Dr. Priyanshu Mathur’s research primarily focuses on rare diseases, metabolic disorders, and inborn errors of metabolism. He has significantly contributed to the establishment of India’s first Rare Diseases Registry, which provides crucial insights into the prevalence and management of rare genetic conditions in the Indian population. His work in neurometabolism and newborn screening has been groundbreaking, particularly in identifying genetic disorders early and enabling early interventions. Dr. Mathur’s research has expanded the understanding of metabolic genetic diseases and their clinical management, making a considerable impact on patient care. He has also been involved in various clinical trials to evaluate the safety and efficacy of treatments for rare diseases such as Duchenne Muscular Dystrophy and Fabry Disease. His research is not only aimed at better clinical outcomes but also at educating the medical community and raising awareness about rare and inherited disorders. His work continues to shape the landscape of pediatric genetics in India.

Publications Top Notes:

  1. Prevalence of obesity and overweight in private schools of Jaipur city in 11-17 year age group children 📊
  2. Correlation study of various factors with germinal matrix intraventricular hemorrhage in preterm neonates 👶
  3. Evaluation of nutritional & educational intervention as KAP and outcome of children with SAM in malnutrition treatment center 🍽️
  4. Chloroquine vs co-artemether in uncomplicated malaria 🦠
  5. Comparison of risk factors and early morbidity in late preterm neonates and term neonates ⚖️
  6. Prevalence of impaired glucose tolerance test and diabetes in overweight, obese and apparently healthy adolescents 🏫
  7. Prevalence of overweight and obesity amongst adolescents and identification of risk factors 🍔
  8. Assessment of parents and child’s attitude as barrier to dietary compliance in celiac disease 🍞
  9. Study on clinical presentations, risk factors and short term outcome of hemorrhagic disease of newborn 🩸
  10. Epidemiological study of HIV-AIDS in children of western Rajasthan 🌍

Conclusion:

Dr. Priyanshu Mathur’s dedication to advancing pediatric medicine through groundbreaking research in genetics and rare diseases, along with his leadership in newborn screening and education, positions him as an exemplary candidate for the Best Researcher Award. His clinical expertise, substantial publication record, and impact on both national and international healthcare systems demonstrate that he is not only a skilled researcher but also a pioneering figure in improving the lives of children affected by genetic and metabolic disorders. With continued expansion into new areas of research and further global collaborations, Dr. Mathur can continue to make an even greater impact on pediatric healthcare worldwide.